|
|
|
Volumn 34 Spec No 1, Issue , 2004, Pages 3-7
|
|
Enfuvirtide, first fusion inhibitor in the treatment of human immunodeficiency virus infection: mechanism of action and pharmacokinetics;Enfuvirtide, premier inhibiteur de fusion dans le traitement de l'infection par le virus de l'immunodéficience humaine: mécanisme d'action et pharmacocinétique.
a
a
HÔTEL DIEU
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR;
PEPTIDE FRAGMENT;
BIOAVAILABILITY;
DOSE RESPONSE;
DRUG EFFECT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
METABOLISM;
REVIEW;
VIRUS REPLICATION;
BIOLOGICAL AVAILABILITY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HIV ENVELOPE PROTEIN GP41;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HIV-1;
HUMANS;
PEPTIDE FRAGMENTS;
VIRUS REPLICATION;
|
|
EID: 14744269571
PISSN: 0399077X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (4)
|
